Hypertension outcomes of adrenalectomy in patients with primary aldosteronism: a systematic review and meta-analysis.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
hyperaldosteronism 3 endocrinologydiseases
hypokalemia 1 endocrinologydiseases
adrenal adenoma 1 endocrinologydiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
adrenal adenoma 2360 present in >5% of hypertensive patients and may exceed 10% [[2]–[4]]. PA is typically caused by an adrenal adenoma and unilateral or bilateral adrenal hyperplasia. However, in a small proportion of cases, adrenal carcinoma
hyperaldosteronism 2497 bilateral adrenal hyperplasia. However, in a small proportion of cases, adrenal carcinoma and familial hyperaldosteronism can also precipitate PA.Idiopathic hyperaldosteronism (IHA) should be medically treated with a mineralocorticoid
hyperaldosteronism 2551 proportion of cases, adrenal carcinoma and familial hyperaldosteronism can also precipitate PA.Idiopathic hyperaldosteronism (IHA) should be medically treated with a mineralocorticoid receptor antagonist, whereas unilateral primary
hyperaldosteronism 4662 2016. The following keywords were used to identify potentially relevant studies from all databases: ‘ hyperaldosteronism ’ and ‘adrenalectomy’. We also retrieved the references from all relevant publications to obtain
hypokalemia 17019 aldosterone secretion is critical in guiding the management of PA. A biochemical cure with normalization of hypokalemia and aldosterone levels is almost certain following adrenalectomy [[7]], however, not all patients are

You must be authorized to submit a review.